STEMSOFT is a well-established division of , led by President and CEO Rob Fuller , and was founded in 1993 by Dr. Allen Eaves .
The field of cellular therapy is moving at breakneck speed. CAR-T, IEC, and other advanced therapy medicinal products (ATMPs) are revolutionizing patient care, transforming how we treat cancer and other diseases. Yet, with this incredible innovation comes a complex reality: managing the data of human cells as a raw material requires unprecedented precision. Kana Lessig Stemsoft Software
Manually tracking these data points—from collection to apheresis, manufacturing, and final infusion—leads to inefficiencies and potential risks. Streamlining Compliance with Configurable Informatics STEMSOFT is a well-established division of , led
However, STEMSOFT is a leader in cell therapy informatics. Here is a blog post tailored to their specialized work. CAR-T, IEC, and other advanced therapy medicinal products
Manufacturing and administering advanced therapies requires complete, accurate, and detailed records. Whether you are a cord blood bank, a public marrow transplant center, or a commercial cell therapy manufacturer, the regulatory landscape is constantly evolving, requiring strict adherence to FACT/JACIE, AABB, cGMP, and cGTP standards.
through barcoding, instrument integration, and automation. Moving Beyond Data Collection